Drug Alert Pearl #17: Naloxone does not treat medetomidine withdrawal; it is a refractory hyperadrenergic crisis requiring alpha-2 agonist management, now confirmed as far north as Rhode Island Read now
Regulatory DEA proposes moving suvorexant, lemborexant, and daridorexant from Schedule IV to Schedule V; comments close September 10 Read now
New Science Four orphine-class synthetic opioids placed on Schedule I effective August 27; no standard immunoassay is designed to detect them; ask your lab if orphine-class targets are in its confirmatory scope Read now
Free ToxSignal: clinical intelligence on drug testing & toxicology Subscribe free →
Drug Alert Pearl #17: Naloxone does not treat medetomidine withdrawal; it is a refractory hyperadrenergic crisis requiring alpha-2 agonist management, now confirmed as far north as Rhode Island Read now
Regulatory DEA proposes moving suvorexant, lemborexant, and daridorexant from Schedule IV to Schedule V; comments close September 10 Read now
New Science Four orphine-class synthetic opioids placed on Schedule I effective August 27; no standard immunoassay is designed to detect them; ask your lab if orphine-class targets are in its confirmatory scope Read now
Free ToxSignal: clinical intelligence on drug testing & toxicology Subscribe free →
Clinical Toxicology · Drug Test Interpretation

When a drug test raises more questions than answers.

ToxiPharm LLC helps drug courts, treatment centers, and legal teams make sense of complex urine drug screen results, delivered by a PharmD with 15+ years of specialized expertise in clinical toxicology and addiction medicine.

ToxSignal: free weekly clinical intelligence Subscribe →
William L. Bundy Jr., PharmD, Clinical Toxicologist
Who We Work With
🏥
Clinicians & Prescribers

Physicians, NPs, and PAs navigating complex drug test results, patient adherence questions, or medication interaction concerns.

⚕️
Treatment Programs

Opioid treatment programs, MAT clinics, and addiction recovery facilities seeking clinical protocol development and compliance support.

⚖️
Drug Courts & Supervision

Problem-solving courts, probation, and parole programs requiring defensible drug testing protocols and expert result interpretation.

🏛️
Legal & Regulatory Bodies

Attorneys, regulatory agencies, and compliance officers who need rigorous, science-based drug test interpretation and toxicology expertise for legal proceedings and compliance matters.

New · Clinical AI Tool
Ask the ToxiPharm Clinical Toxicology Assistant

Get high-level, source-grounded answers to drug testing questions, drawn from SAMHSA, ASAM, Baselt, and ToxiPharm's curated reference library. Educational use. Cites sources. Won't guess.

Try the Assistant →
Educational use only · Not medical advice
15+
Years Clinical
Experience
3
Peer-Reviewed Journals
JAMA Psychiatry · DAD
2
State Pharmacy Licenses
Virginia · Florida
3
Specialty Areas
Pain · Addiction · Toxicology
UF
Clinical Asst. Professor
College of Pharmacy
ToxSignals Intelligence

Get ToxSignals in Your Inbox

Free clinical intelligence on emerging drug threats, delivered directly to you.

No spam. Unsubscribe anytime.

Ready to Work Together?
Let's discuss your specific challenge.

Whether you're interpreting a complex drug test result, building a treatment protocol, or preparing expert testimony, we bring the clinical depth and toxicology expertise your situation requires.